Loss of tumorigenicity of human breast cancer cells engineered to produce IL-2, IL-4 or GM-CSF in nude mice

Int J Oncol. 1999 Nov;15(5):943-7. doi: 10.3892/ijo.15.5.943.

Abstract

Human breast cancer cells (OCUB-M), retrovirally transduced with granulocyte macrophage-colony stimulating factor (GM-CSF), interleukin-2 (IL-2) or IL-4 gene were examined for their antitumor activities in nude mice. Although cell proliferation rates in vitro of these cytokine-producing cells were not significantly different from that of wild-type cells, nude mice that were subcutaneously inoculated with cytokine-producing cells did not develop tumors in contrast to mice that were injected with wild-type cells. Injection of GM-CSF-producing cells into the vicinity of growing wild-type tumors retarded subsequent growth of wild-type tumors. Histological examination of tumors which received GM-CSF-producing cells revealed marked infiltration of mononuclear cells around the tumors. Irradiation of cytokine-producing cells diminished their proliferation capacity but production of cytokine(s) was retained. Therefore, inoculation of irradiated cytokine producer cells into growing tumors can be used as a therapeutic maneuver for breast cancer.

MeSH terms

  • Animals
  • Breast Neoplasms / immunology*
  • Breast Neoplasms / pathology*
  • Cell Division
  • Cell Survival / radiation effects
  • Female
  • Granulocyte-Macrophage Colony-Stimulating Factor / biosynthesis
  • Granulocyte-Macrophage Colony-Stimulating Factor / genetics*
  • Humans
  • Interleukin-2 / biosynthesis
  • Interleukin-2 / genetics*
  • Interleukin-4 / biosynthesis
  • Interleukin-4 / genetics*
  • Mice
  • Mice, Nude
  • Recombinant Proteins / biosynthesis
  • Transfection
  • Transplantation, Heterologous
  • Tumor Cells, Cultured

Substances

  • Interleukin-2
  • Recombinant Proteins
  • Interleukin-4
  • Granulocyte-Macrophage Colony-Stimulating Factor